2001年

  1. Matsumori A: Are the better clinical outcomes conferred by heart failure drugs attributable to thier effects on cytokines? ISCP/JCS Joint Symposium 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  2. Matsumori A: Emerging role of immunomodulation in the management of heart failure in the 21st century. Symposium 24. Assessment for prognosis in heart failure. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  3. Matsumori A: Pathogenesis and diagnosis of hepatitis C virus myocarditis and cardiomyopathy. JS1. Etiology and treatment of myocarditis. WHF / ISCP Symposium. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  4. Matsumori A: Beneficial effects of oral candesartan in congestive heart failure; the assessment of response to candesartan in heart failure in Japan. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  5. Matsumori A: Role of cytokines in heart failure, The XVII World Congress of the International Society for Heart Research, July 6-11, Winnipeg, Canada.
  6. Matsumori A: Infection, immunity and cytokines in cardiovascular diseases 5th International Congress of Polish Cardiac Society, September 29, Warsaw, Poland.
  7. Matsumori A: Trial presentation: ARCH-J. The First WHF Global Conference on Cardiovascular Clinical Trials, November 21-23, Hong Kong SAR, China.
  8. Matsumori A: Inotropic agent in the treatment of chronic heart failure. The First WHF Global Conference on Cardiovascular Clinical Trials, November 21-23, Hong Kong SAR, China.
  9. Matsumori A: Trial presentation: EPOCH. The First WHF Global Conference on Cardiovascular Clinical Trials, November 21-23, Hong Kong SAR, China.
  10. Nishimura H, Tanaka Y, Okazaki T, Nakatani K, Hara M, Matsumori A, Sasayama S, Hiai H, Minato N, Honjo T : Autoimmune dilated cardiomyopathy in PD-1 receptor deficient mice. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  11. Furukawa Y, Boring L, Charo IF, Libby P, Mitchell RN : C-C Chemokine Receptor 2 Deficiency attenuates graft arterial diseases in MHC 1-disparate murine cardiac allografts.10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  12. Nishio R, Matsumori A, Sasayama S : Carvedilol increases the production of interferon-γ by human mononuclear cells : possible mechanism for its effect in viral myocarditis.10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  13. Miyamoto T, Matsumori A, Hwang MH, Nishio R, Ito H, Sasayama S : A new immunosuppressive agent FTY720 is effective in a murine model of acute viral myocarditis. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  14. Ito H, Matsumori A, Ono K, Nishio R, Sasayama S : Amiodarone inhibits interleukin-6 production and attenuates myocardial injury induced by viral myocarditis in mice. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  15. Hara M, Matsumori A, Ono K, Hwang MW, Nakatani K, Sasayama S : Mast cell stabilizer prevents the evolution from compensated hypertrophy to congestive heart failure. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  16. Hara M, Kitaura-Inenaga K, Matsumori A, Ono K, Sasayama S : Gene expression of cardiac mast cell tryptase in mouse viral myocarditis. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  17. Nishio R, Matsumori A, Sasayama S: Analysis of the left ventricular pressure-volume relationship in a closed-chest murine model of congestive heart failure due to viral myocarditis. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  18. Furukawa Y, Fukumoto Y, Libby P, Mitchell RN : Wild type but not interferon-γ T cells suffice inducing graft arterial disease in murine cardiac allografts in recombination- activating gene-1-deficient mice. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  19. Nakano A, Matsumori A, Kimura H, Nakamura H, Miyamoto T, Ono K, Ohashi N, Yodoi J, Sasayama S : Thioredoxin attenuates myocardial ischemia / reperfusion injury by inhibiting the activation of NF-kB. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  20. Nakano A, Matsumori A, Ono K, Ito H, Okada M, Sasayama S : Insulin-like growth factor-1 boosts viral titers and aggravates the course of acute viral myocarditis in mice. 10th International Congress on Cardiovascular Phamacotherapy, March 27-30, Kyoto.
  21. Ono T, Liu N, Kasuno K, Nogaki F, Makino T, Muso E, Sasayama S: Antiproliferative effects of benidipine on cultured human mesangial cells in relation to cell cycle. The 10th International Congress on Cardiovascular Pharmacotherapy, March 27-30, Kyoto
  22. Kusano H, Nogaki F, Kobayashi I, Takeda T, Ono T, Miyawaki S, Yoshida H, Muso E, Sasayama S : Long-tern administration of angiotensin converting enzyme inhibitor (ACEI)induces arteriolohypertrophy which mimics renin-angiotensin system (RAS) knock-out mice in murine kidney. The 10th International Congress on Cardiovascular Pharmacotherapy, March 27-30, Kyoto.
  23. Liu N, Ono T, Makino T, Nogaki F, Muso E, Honda G : Involvement of extracellular matrix accumulation in coagulation through factor V expression on mesangioproliferative glomerulonephritis in rats. ASN / ISN World Congress of Nephrology, October 10-17, San Francisco.
  24. Makino T, Ono T, Nakamura T, Liu N, Nogaki F, Muso E, Honda G : Suppressive effects of rosmarinic acid on mesangioproliferative glomerulonrphritis in rats. ASN / ISN World Congress of Nephrology, October 10-17, San Francisco.
  25. Suyama K, Shirakawa K, Ono T, Yodoi J, Muso E : Thioredoxin (TRX)a potent early and protective marker against oxidative stress (OS)in proximal tubuli in active IgA nephropathy. ASN / ISN World Congress of Nephrology, October 10-17, San Francisco.
  26. Kusano H : Angiotensin converting enzyme inhibitor (ACEI)protected against progression of glomerulosclerosis through significant suppresion of abnormal cell proliferation and apoptosis in remnant kidney model of high IgA strain (HIGA)of ddY mice. ASN / ISN World Congress of Nephrology, October 10-17, San Francisco.
  27. Nogaki F, Kmatata T, Ono T, Ye SK, Miyawaki S, Muso E, Yoshida H, Honjo T : Genetic analysis of abnormal IgA character in high IgA (HIGA)mice, a model of IgA nephropathy, by crossing with BALB/c mice. ASN / ISN World Congress of Nephrology, October 10-17, San Francisco.
  28. Kataoka K, Nohara R, Hasegawa K, Yanazume T, Hirai T, Sawamura T, Fujita M, Sasayama S : Blockade of lectin-like oxidized low-density lipoprotein receptor reduces myocardial infarction size after ischemia-reperfusion, 50th Annual Scientific Session of the American College of Cardiology, March 19-22, Orland.
  29. Hosokawa R, Nohara R, Hirai T, Kataoka K, Masuda D, Sasayama S : Predictive values for the effectiveness of b-blocker therapy in patients with chronic heart failure - I-123 MIBG versus endogenous cardiac natriuretic peptides -, 10th International Congress on Cardiovascular Pharmacotherapy, March 27-30, Kyoto.
  30. Masuda D, Nohara R, Hosokawa R, Kataoka K, Chen L, Kambara N, Fujita M, Sasayama S: Angiotensin converting enzyme inhibitor improves microvascular circulation and CFR in patients of ischemic heart disease (IHD)with diabetes mellitus using ammonia PET, 10th International Congress on Cardiovascular Pharmacotherapy, March 27-30, Kyoto.
  31. Hosokawa R, Nohara R, Korhonen M, Hirai T, Masuda D, Chen L-G, Kambara N, Tadamura E, Konishi J, Sasayama S: Clinical significances of low washout rate of I-123 MIBG on scintigraphic images in patients with chronic heart failure, 5th International Conference of Nuclear Cardiology, May 2-5, Vienna.
  32. Masuda D, Nohara R, Kataoka K, Hosokawa R, Chen L-G, Kambara N, Kubo S, Tadamura E, Fujita M, Sasayama S : The new therapy of enhanced external counterpulsation combined with heparin improves oxygen metabolism of ischemic myocardium, 5th International Conference of Nuclear Cardiology, May 2-5, Vienna.
  33. Kataoka K, Nohara R, Hirai T, Chen L-G, Hosokawa R, Sasayama S: Impared myocardial fatty acid metabolism precedes left-ventricular hypertrophy in pressure-overloaded rats, 5th International Conference of Nuclear Cardiology, May 2-5, Vienna.
  34. Hosokawa R, Nohara R, Masuda D, Kataoka K, Hirai T, Kambara N, Tadamura E, Konishi J, Sasayama S : Predictive values for the effectiveness of b-blockers therapy in patients with chronic heart failure - 11C-acetate versus endogenous cardiac natriuretic peptides -, 48th Annual Meeting of the Society of Nuclear Medicine, June 23-27, Toronto.
  35. Masuda D, Nohara R, Kataoka K, Hosokawa R, Kambara N, Fujita M : Enhanced external counterpulsation promotes angiogenesis factors in patients with chronic stable angina, 74th Scientific Session of the American Heart Association, November 11-14, Anaheim.
  36. Masuda D : Pulse waves promote vessel growth to ease chest pain. The New Releases in the home page on The Scientific Session 2001 of the American Heart Association, The Interview of 74th Scientific Session of the American Heart Association, November 11-14, Anaheim.
  37. Kataoka K, Hasegawa K, Nohara R, Yanazume T, Iwai-Kanai E, Hirai T, Sawamura T, Fujita M: Myocardial LOX-1 pathway affects the extent of myocardial ischemia- reperfusion injury, 74th Scientific Session of the American Heart Association, November 11-14, Anaheim.
  38. Horie M, Takano M, Xie LH, Kono Y, Ninomiya T: Phospholipase C linked receptors inhibit Sarcorummal ATP-sensitive K+channel through metaborism of membrane phosphatidyl 4,5 bisphosphate in rat ventricular myocytes. North American Society of Pacing and Electrophysiology, May 5, Boston.
  39. Ninomiya T, Takano M, Haruna T, Kono Y, Yoshida H, Kubota T, Kobori A, Horie M.: Verapamil, a CA2+ entry brocker,targets pore-forming subumit of cardiac type KATP channel (Kir6.2)North American Society of Pacing and Electrophysiology, May 5, Boston.
  40. Obayashi K, Doi O, Yoshida H, Sakata K, Nawada R, Isikawa J, Tamekiyo H, Horie M, Sasayama S.:Double shortening of stimulua-atrial interval during subvalvular pcing: Apropriate ABLA-tion site detection in left-side accessory atrioventricular pathways. North American Society of Pacing and Electrophysiology, May 5, Boston.
  41. Horie M, Yoshida H, Kono Y, Haruna T, Kubota T, Kobori A, Ninomiya T, Yamashita F, Aizawa Y. Genotype/phenotype relationships in LQT1 patients. North American Society of Pacing and Electrophysiology, May 5, Boston.
  42. Yoshida H, Horie M, Otani H, Kubota T, Ninomiya T, Kobori A, Takenaka K, Takano M, Tsuchiya K. A novel mechanism of Long-QT Syndrome: activation of cryptic acceotor site by an intronic mutation in HERG gene. American Heart Association Scientific Meeting, November 13. Anaheim.
  43. Inagaki K, Kihara Y, Hayashida W, Iwanaga Y, Yasaka A, Sasayama S. Myocardial PKCe, but not PKCb, activation is mechano-sensitive and plays a compensatory role in ventricular hypertrophy in hypertensive rats. The 50th Annual Scientific Session, American College of Cardiology, March 18-20, Orland.
  44. Takimoto Y, Aoyama T, Iwanaga Y, Izumi T, Kihara Y, Sasayama S. Increased expression of cardiotrophin-1 and gp130 during transition from hypertrophy to ventricular dilatation in hypertensive rats. American College of Cardiology, March 18-20, Orland.
  45. Takenaka H, Kihara Y, Inagaki K, Yoneda T. A cardioprotective agent, JTV519, inhibits apoptotic cell death of post-ischemic reperfused myocardium through dPKC- mediated ERK activation. Scientific Conference on Molecular, Integrative, and Clinical Approaches to Myocardial Ischemia, American Heart Association, August 8-12, Seattle.
  46. Yoneda T, Kihara Y, Izumi T, Sarai N, Iwanaga Y, Inagaki K, Onozawa Y, Takenaka H, Noma A. Re-expression of T-type calcium channels in the failing myocardium is mediated by activation of local endothelin-1 system. Scientific Sessions 2001, American Heart Association, November 10-14, Anaheim.
  47. Kihara Y. Pathophysiological roles of angiotensin Ⅱversus endothelin-1 on the myocardium during transition from hypertrophy to failure: Studies in Dahl salt-sensitive rats with hypertension. Invited Lecture, Department of Cardiology, Stanford University, November 28, Palo Alto
  48. Hasegawa K, Iwai-Kanai E, Sasayama S. Differential Regulation of Myocardial Cell Apoptosis by α-and β-Adrenergic Pathways. 9th International Catecholamine Symposium. April 1-5, Kyoto
  49. Wada H, Morimoto T, Abe M, Hasegawa K. Acetylation of GATA-6 by p300 and PCAF is Involved in Smooth Muscle-Specific Transcription. American Heart Association Scientific Sessions 2001. November 11-14, Anaheim
  50. Kataoka K, Hasegawa K, Nohara R, Yanazume T, Iwai-Kanai E, Hirai T, Sawamura T, Fujita M. Myocardial LOX-1 Pathway Affects the Extent of Myocardial Ischemia- Reperfusion Injury. American Heart Association Scientific Sessions 2001. November 11-14, Anaheim
  51. Kawamura T, Kakita T, Wada H, Iwai-Kanai E, Yanazume T, Hasegawa K. A p300 Protein Protects Cardiac Myocytes from Doxorubicin-Induced Apoptosis in Adult Mice In Vivo. American Heart Association Scientific Sessions 2001. November 11-14, Anaheim
  52. Yanazume T, Morimoto T, Wada H, Abe M, Kawamura T, Hasegawa K. Rho/ROCK Pathway Is Required for the Activation of ERKs/GATA-4 during α1-Adrenergic Agonist-Stimulated Myocardial Cell Hypertrophy. American Heart Association Scientific Sessions 2001. November 11-14, Anaheim
  53. Abe M, Wada H, Kawamura T, Hasegwawa K. Phosphorylation of GATA-6 is Involved in PPARγ-Mediated Activation of Differentiated Phenotype in Human Vascular Smooth Muscle Cells. American Heart Association Scientific Sessions 2001. November 11-14, Anaheim
  54. Kawamura T, Hasegawa K, Yanazume T, Morimoto T, Fujita M, Iwakura A, Nomoto T, Nishina T, Komeda M. Alteration of Apoptosis Signal Transduction Pathways following Left Ventricular Reduction Surgery in Heart Failure of Adult Rats. American Heart Association Scientific Sessions 2001. November 11-14, Anaheim
  55. Takimoto Y, Aoyama T, Keyamura R, Yui Y, Sasayama S. Augmented protein expression of neuronal nitric oxide synthase in the atria parasympathetically decreases heart rate during acute myocardial infarction in rats. 50th. ACC, March 19-22, Orland
  56. Takimoto Y, Aoyama T, Keyamura R, Yui Y, Sasayama S. Neuronal nitric oxide synthase (nNOS)expression in the atria and its role in the heart rate regulation in the rat model of myocardial infarction. ISCP, March 27-30, Kyoto
  57. Takimoto Y, Aoyama T, Iwanaga Y, Izumi T, Kihara Y, Sasayama S. Augmented expression of cardiotrophin-1 but not leukemia inhibitory factor during transition from hypertrophy to ventricular dilatation in hypertensive rats. XXIV ESC. Sep. 1-5, Stockholm
  58. Takimoto Y, Aoyama T, Keyamura R, Yui Y, Sasayama S. Neuronal nitric oxide synthase (nNOS)expression in the atria and its role in the heart rate regulation in the rat model of myocardial infarction. XXIV ESC. Sep. 1-5, Stockholm
  59. Shioji K, Kishimoto C, Sasayama S, Nakamura H, Yodoi J : Upregulation of thioredoxin (TRX)expression in giant cell myocarditis in rats. 10th International Congress on Cardiovascular Pharmacotherapy. March 27-30, Kyoto
  60. Shioji K, Kishimoto C, Nakayama Y, Sasayama S. Therapy with immunoglobulin ameliorates giant cell myocarditis in rats. March 27-30, Kyoto
  61. Shioji K, Kishimoto C : Therapy with immunoglobulin ameliorates experimental giant cell myocarditis in rats. A novel Fc receptor-mediated and dendric cell suppressing mechanisms. The 74th Scientific Sessions of American Heart Association. November 11-14, Anaheim
  62. Kishimoto C, Shioji K : Protection against murine coxsackievirus B3 myocarditis by T cell vaccination. The 74th Scientific Sessions of American Heart Association. November 11-14, Anaheim
  63. Kishimoto C, Shioji K : Treatment with an antibody against macrophage inflammatory protein-2 prevents myocardial inflammation in murine viral myocarditis. The 74th Scientific Sessions of American Heart Association. November 11-14, Anaheim
  64. Kishimoto C, Shioji K : Active myocarditis is transferable in severe combined immunodeficient mice by antigen-sensitized T cells. The 74th Scientific Sessions of American Heart Association. November 11-14, Anaheim
  65. Kishimoto C, Shioji K, Nakamura H, Yodoi J : Thioredoxin transgenic mice attenuates adriamycin-induced cardiomyopathy. Redox Kyoto, November 3 , Kyoto
  66. Kishimoto C, Shioji K, Yuan Z, Nimata M, Fujiki M : Therapy with immunoglobulin ameliorates giant cell myocarditis in rats. The 7th International Kawasaki Disease Symposium, December 4-7 Hakone
  67. Yasaka A, Hayashida W. Stretch-induced cardiac p38-MAP kinase activation is decreased in the failing rat heart. The European society of cardiology XXIII congress, September 1-5, Stockholm, Sweden
  68. Yasaka A, Hayashida W. Altered expression of frizzled protein genes in the aorta of rats with genetic hypertrophy. Scientific Sessions 2001 American Heart Association, November 11-14, Anaheim
  69. Yasaka A, Hayashida W. The frizzled andβ-catenin signaling in the hypertrophied and failing rat hearts. Scientific Sessions 2001 American Heart Association, November 11-14, Anaheim
  70. Kinugawa T, Ogino K, Osaki S, Kato M, Endo A, Igawa O, Hisatome I, Shigemasa C, Fujita M: Exercise plasma norepinephrine levels as a prognostic marker for cardiac death in patients with mild heart failure. The 50th Annual Scientific Session of the American College of Cardiology, March 18-21, Orland
  71. Miyamoto S, Nagaya N, Tambara K, Iwase T, Ueda K, Yamazato A, Tamaki S, Komeda M, Fujita M: Elevation of pericardial fluid matrix metalloproteinase-2 (MMP-2)level is closely associated with left ventricular dilation and myocardial remodeling. The 50th Annual Scientific Session of the American College of Cardiology, March 18-21, Orland
  72. Iwakura A, Fujita M, Tabata Y, Ikai A, Yanazume T, Komeda M: Intravenous infusion of basic fibroblast growth factor prevents monocrotaline-induced pulmonary hypertension in rats. The 50th Annual Scientific Session of the American College of Cardiology, March 18-21, Orland
  73. Kataoka K, Nohara R, Hasegawa K, Yanazume T, Hirai T, Sawamura T, Fujita M, Sasayama S: Blockade of lectin-like oxidized low-density lipoprotein receptor reduces myocardial infarction size after ischemia-reperfusion. The 50th Annual Scientific Session of the American College of Cardiology, March 18-21, Orland
  74. Kakita T, Hasegawa K, Fujita M, Hiki K, Yanazume T, Sasayama S: Activation of K+-Cl--cotransporters is involved in the increase in cell volume during a 1-adrenergic agonist-stimulated hypertrophy in cardiac myocytes. The 50th Annual Scientific Session of the American College of Cardiology, March 18-21, Orland
  75. Fujita M, Masuda D, Nohara R, Sasayama S: Heparin potentiates coronary collateral arteriogenesis. The 10th International Congress on Cardiovascular Pharmacotherapy, March 27-30, Kyoto
  76. Kinugawa T, Fujita M, Lee JD, Nakajima H, Hanada H, Miyamoto S: Efficacy of sarpogrelate, a novel serotonin blocker, on anginal symptom and exercise capacity in stable angina patients with well-developed collaterals. The 10th International Congress on Cardiovascular Pharmacotherapy, March 27-30, Kyoto
  77. Inoko M, Fujita M, Nakae I, Tamaki S, Watanuki M, Hashimoto T, Konishi T: Effects of chronic ACE inhibition on sympathetic activity in patients with mild to moderate heart failure. The 10th International Congress on Cardiovascular Pharmacotherapy, March 27-30, Kyoto
  78. Fujita M: Angiogenic therapy by coronary collateral recruitment and arteriogenesis. The 18th World Congress of the International Society for Heart Research, July 6-11, Winnipeg
  79. Iwakura A, Tabata Y, Koyama T, Doi, K, Kataoka K, Nohara R, Fujita M, Nishimura K: Gelatin sheet incorporating basic fibroblast growth factor enhances healing of the devascularized sternum in a large animal model. The 74th Scientific Meeting of the American Heart Association, November 11-14, Anaheim
  80. Kawamura T, Hasegawa K, Yanazume T, Morimoto T, Fujita M, Iwakura A, Nomoto T, Nishina T, Komeda M: Alteration of apoptosis signal transduction pathways following left ventricular reduction surgery in heart failure of adult rats. The 74th Scientific Meeting of the American Heart Association, November 11-14, Anaheim

ページの先頭へ